The Cost of Innovation and Evidence in Cardiac Surgery
This review summarizes a systematic analysis of 216 randomized trials of cardiovascular interventions performed during 2008–2019, according to the source of trial funding.
World's Largest Resource for Cardiovascular Perfusion
This review summarizes a systematic analysis of 216 randomized trials of cardiovascular interventions performed during 2008–2019, according to the source of trial funding.
Levosimendan, a calcium sensitizer and potassium channel opener, has been demonstrated to improve myocardial function without increasing oxygen consumption and to show protective effects in other organs.
Because the Revolution centrifugal pump, which was recently designed and distributed, produced results comparable with those obtained with the BioPump, it should be considered as safe as the Bio-Pump to perform clinical CPB.